Quantum Biopharma Ltd. submitted a FORM 6-K filing on March 31, 2025, detailing its compliance under the Securities Exchange Act. The filing is noted for continuing to use Form 20-F for annual reports.
AI Assistant
QUANTUM BIOPHARMA LTD
2025
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.